Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion type Assertion NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_head.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion description "[Indeed, we show here that mTOR inhibition by the use of rapamycin is sufficient to halt tumor progression in this genetically defined oral cancer model system, thereby prolonging animal survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_provenance.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion evidence source_evidence_literature NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_provenance.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion SIO_000772 19435901 NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_provenance.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion wasDerivedFrom befree-20140225 NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_provenance.
- NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_assertion wasGeneratedBy ECO_0000203 NP808905.RAdvED2DFrAj1clxBNRnuVhJ6pxKCqUmezuEbNXv6fAa0130_provenance.